Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Kaniewska

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Polish Archives of Internal Medicine|July 19, 2019
Efficacy, tolerability, and safety of infliximab biosimilar in comparison to originator biologic and adalimumab in patients with Crohn diseaseMagdalena Kaniewska, Mariusz Rosołowski, Grażyna Rydzewska
Przeglad Gastroenterologiczny|November 11, 2017
The efficacy and safety of the biosimilar product (Inflectra<sup>®</sup>) compared to the reference drug (Remicade<sup>®</sup>) in rescue therapy in adult patients with ulcerative colitisMagdalena Kaniewska, Andrzej Moniuszko, Grażyna Rydzewska
Przeglad Gastroenterologiczny|April 3, 2023
Gastrointestinal symptoms in COVID-19Konrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, et al.
Przeglad Gastroenterologiczny|September 29, 2021
Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naïve and non-naïve patientsMagdalena Kaniewska, Mariusz Rosolowski, Andrzej Moniuszko, et al.
Przeglad Gastroenterologiczny|July 7, 2025
Sexual dysfunction in patients with inflammatory bowel diseaseMagdalena Kaniewska, Konrad Lewandowski, Dorota Szydlarska, et al.
Przeglad Gastroenterologiczny|September 21, 2022
Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?Konrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, et al.
Przeglad Gastroenterologiczny|October 2, 2020
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumabPiotr Zielecki, Magdalena Kaniewska, Mariusz Furmanek, et al.
Przeglad Gastroenterologiczny|April 4, 2022
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndromeKonrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, et al.
Journal of Clinical Medicine|July 2, 2021
The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with VedolizumabKonrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, et al.
Nutrients|November 11, 2022
Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBDMartyna Więcek, Paulina Panufnik, Magdalena Kaniewska, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Polish Archives of Internal Medicine|July 19, 2019
Efficacy, tolerability, and safety of infliximab biosimilar in comparison to originator biologic and adalimumab in patients with Crohn diseaseMagdalena Kaniewska, Mariusz Rosołowski, Grażyna Rydzewska
Przeglad Gastroenterologiczny|November 11, 2017
The efficacy and safety of the biosimilar product (Inflectra<sup>®</sup>) compared to the reference drug (Remicade<sup>®</sup>) in rescue therapy in adult patients with ulcerative colitisMagdalena Kaniewska, Andrzej Moniuszko, Grażyna Rydzewska
Przeglad Gastroenterologiczny|April 3, 2023
Gastrointestinal symptoms in COVID-19Konrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, et al.
Przeglad Gastroenterologiczny|September 29, 2021
Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naïve and non-naïve patientsMagdalena Kaniewska, Mariusz Rosolowski, Andrzej Moniuszko, et al.
Przeglad Gastroenterologiczny|July 7, 2025
Sexual dysfunction in patients with inflammatory bowel diseaseMagdalena Kaniewska, Konrad Lewandowski, Dorota Szydlarska, et al.
Przeglad Gastroenterologiczny|September 21, 2022
Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) - friend or foe?Konrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, et al.
Przeglad Gastroenterologiczny|October 2, 2020
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumabPiotr Zielecki, Magdalena Kaniewska, Mariusz Furmanek, et al.
Przeglad Gastroenterologiczny|April 4, 2022
The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndromeKonrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, et al.
Journal of Clinical Medicine|July 2, 2021
The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with VedolizumabKonrad Lewandowski, Magdalena Kaniewska, Mariusz Rosołowski, et al.
Nutrients|November 11, 2022
Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBDMartyna Więcek, Paulina Panufnik, Magdalena Kaniewska, et al.
Pageof 4